Skip to main content
Top

Cancer and Metastasis Reviews

Issue 1/2011

Special Issue: Immunity and Tumor Growth and Metastasis

Content (13 Articles)

Preface

Wolf H. Fridman

Open Access

Tumor immunosurveillance in human cancers

Bernhard Mlecnik, Gabriela Bindea, Franck Pagès, Jérôme Galon

Tumor microenvironment is multifaceted

Catherine Sautès-Fridman, Julien Cherfils-Vicini, Diane Damotte, Sylvain Fisson, Wolf Hervé Fridman, Isabelle Cremer, Marie-Caroline Dieu-Nosjean

Myeloid cell diversification and complexity: an old concept with new turns in oncology

Mariacristina Chioda, Elisa Peranzoni, Giacomo Desantis, Francesca Papalini, Erika Falisi, Solito Samantha, Susanna Mandruzzato, Vincenzo Bronte

The significant role of mast cells in cancer

Khashayarsha Khazaie, Nichole R. Blatner, Mohammad Wasim Khan, Fotini Gounari, Elias Gounaris, Kristen Dennis, Andreas Bonertz, Fu-Nien Tsai, Matthew J. Strouch, Eric Cheon, Joseph D. Phillips, Philipp Beckhove, David J. Bentrem

Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy

Oliver Kepp, Lorenzo Galluzzi, Isabelle Martins, Frederic Schlemmer, Sandy Adjemian, Mickael Michaud, Abdul Qader Sukkurwala, Laurie Menger, Laurence Zitvogel, Guido Kroemer

How to improve the immunogenicity of chemotherapy and radiotherapy

Yuting Ma, Rosa Conforti, Laetitia Aymeric, Clara Locher, Oliver Kepp, Guido Kroemer, Laurence Zitvogel

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

Eric Tartour, H. Pere, B. Maillere, M. Terme, N. Merillon, J. Taieb, F. Sandoval, F. Quintin-Colonna, K. Lacerda, A. Karadimou, C. Badoual, A. Tedgui, W. H. Fridman, S. Oudard

Immunomodulating antibodies and drugs for the treatment of hematological malignancies

Roch Houot, Holbrook Kohrt, Matthew J. Goldstein, Ronald Levy

Tumor immune surveillance and ovarian cancer

Lana E. Kandalaft, Gregory T. Motz, Jaikumar Duraiswamy, George Coukos

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine